Order Article Reprints

Alexandrova Y, Yero A, Mboumba Bouassa R-S, Comeau E, Samarani S, Brumme ZL, Hull M, Crawley AM, Langlois M-A, Angel JB, et al. SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study). Viruses. 2023; 15(2):575. https://doi.org/10.3390/v15020575

Alexandrova, Yulia, Alexis Yero, Ralph-Sydney Mboumba Bouassa, Eve Comeau, Suzanne Samarani, Zabrina L. Brumme, Mark Hull, Angela M. Crawley, Marc-André Langlois, Jonathan B. Angel, and et al. 2023. "SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)" Viruses 15, no. 2: 575. https://doi.org/10.3390/v15020575

Alexandrova, Y., Yero, A., Mboumba Bouassa, R.-S., Comeau, E., Samarani, S., Brumme, Z. L., Hull, M., Crawley, A. M., Langlois, M.-A., Angel, J. B., Cooper, C. L., Needham, J., Lee, T., Singer, J., Anis, A. H., Costiniuk, C. T., & Jenabian, M.-A. (2023). SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study). Viruses, 15(2), 575. https://doi.org/10.3390/v15020575